127 related articles for article (PubMed ID: 38159645)
41. Propranolol and infantile hemangiomas four years later: a systematic review.
Marqueling AL; Oza V; Frieden IJ; Puttgen KB
Pediatr Dermatol; 2013; 30(2):182-91. PubMed ID: 23405852
[TBL] [Abstract][Full Text] [Related]
42. Propranolol and infantile hemangiomas: different routes of administration, a randomized clinical trial.
Zaher H; Rasheed H; Esmat S; Hegazy RA; Gawdat HI; Hegazy RA; El-Komy M; Abdelhalim DM
Eur J Dermatol; 2013; 23(5):646-52. PubMed ID: 24135427
[TBL] [Abstract][Full Text] [Related]
43. Propranolol vs corticosteroids for infantile hemangiomas: a multicenter retrospective analysis.
Price CJ; Lattouf C; Baum B; McLeod M; Schachner LA; Duarte AM; Connelly EA
Arch Dermatol; 2011 Dec; 147(12):1371-6. PubMed ID: 21844428
[TBL] [Abstract][Full Text] [Related]
44. Preliminary results of propranolol treatment for patients with infantile hemangioma.
Corapcioğlu F; Büyükkapu-Bay S; Binnetoğlu K; Babaoğlu A; Anik Y; Tugay M
Turk J Pediatr; 2011; 53(2):137-41. PubMed ID: 21853649
[TBL] [Abstract][Full Text] [Related]
45. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study.
Zvulunov A; McCuaig C; Frieden IJ; Mancini AJ; Puttgen KB; Dohil M; Fischer G; Powell J; Cohen B; Ben Amitai D
Pediatr Dermatol; 2011; 28(2):94-8. PubMed ID: 21362031
[TBL] [Abstract][Full Text] [Related]
46. The use of propranolol for complicated infantile hemangiomas.
Vercellino N; Romanini MV; Pelegrini M; Rimini A; Occella C; Dalmonte P
Int J Dermatol; 2013 Sep; 52(9):1140-6. PubMed ID: 23829783
[TBL] [Abstract][Full Text] [Related]
47. Individualized dosing of oral propranolol for treatment of infantile hemangioma: a prospective study.
Prasad A; Sinha AK; Kumar B; Prasad A; Kumari M
Pan Afr Med J; 2019; 32():155. PubMed ID: 31303926
[TBL] [Abstract][Full Text] [Related]
48. Late rebound of infantile hemangioma after cessation of oral propranolol.
Shehata N; Powell J; Dubois J; Hatami A; Rousseau E; Ondrejchak S; McCuaig C
Pediatr Dermatol; 2013; 30(5):587-91. PubMed ID: 24016283
[TBL] [Abstract][Full Text] [Related]
49. Quality of life improving after propranolol treatment in patients with Infantile Hemangiomas.
Pensabene M; Di Pace MR; Baldanza F; Grasso F; Patti M; Sergio M; La Placa S; Giuffre' M; Serra G; Casuccio A; Cimador M
Ital J Pediatr; 2022 Aug; 48(1):140. PubMed ID: 35927685
[TBL] [Abstract][Full Text] [Related]
50. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
[TBL] [Abstract][Full Text] [Related]
51. Safety assessment during initiation and maintenance of propranolol therapy for infantile hemangiomas.
Babiak-Choroszczak L; Giżewska-Kacprzak K; Dawid G; Gawrych E; Bagłaj M
Adv Clin Exp Med; 2019 Mar; 28(3):375-384. PubMed ID: 30659785
[TBL] [Abstract][Full Text] [Related]
52. Monitoring oral propranolol for infantile hemangiomata.
Bar J; Bar-Ilan E; Cleper R; Sprecher E; Samuelov L; Mashiah J
Dermatol Ther; 2022 Nov; 35(11):e15870. PubMed ID: 36177767
[TBL] [Abstract][Full Text] [Related]
53. Adverse effects of propranolol treatment for infantile hemangiomas in China.
Jian D; Chen X; Babajee K; Su J; Li J; Hu X; Xie H; Li J
J Dermatolog Treat; 2014 Oct; 25(5):388-90. PubMed ID: 23216314
[TBL] [Abstract][Full Text] [Related]
54. Blood Pressure Monitoring During the Induction and Maintenance Period of Propranolol Therapy for Complicated Infantile Hemangiomas: A Prospective Study of 109 Infants.
Hengst M; Oelert M; Hoeger PH
Pediatr Dermatol; 2015; 32(6):802-7. PubMed ID: 26391729
[TBL] [Abstract][Full Text] [Related]
55. Transient hypertriglyceridaemia associated with propranolol for treatment of infantile hemangioma.
Farshchian M; Potts GA
Australas J Dermatol; 2021 Nov; 62(4):e580-e581. PubMed ID: 34293182
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of cases with infantile hemangioma requiring treatment.
Maraşli H; Acipayam C; Güllü UU; Dinçer S; Dalgiç EF; Karaküçük SN; Yurttutan S
Folia Med (Plovdiv); 2022 Feb; 64(1):67-74. PubMed ID: 35851882
[TBL] [Abstract][Full Text] [Related]
57. Propranolol treatment for infantile hemangioma: a case series of sixty-two patients.
Stringari G; Barbato G; Zanzucchi M; Marchesi M; Cerasoli G; Tchana B; Gritti A; Boccaletti V; Lombardi AA; Carano N
Pediatr Med Chir; 2016 Jun; 38(2):113. PubMed ID: 27345601
[TBL] [Abstract][Full Text] [Related]
58. Is prolonged monitoring necessary? An updated approach to infantile hemangioma treatment with oral propranolol.
Johansen ML; Mahendran G; Lawley LP
Pediatr Dermatol; 2021 Jul; 38(4):800-805. PubMed ID: 34115417
[TBL] [Abstract][Full Text] [Related]
59. Rare complication - skin atrophy - after systemic conservative therapy of infantile hemangioma.
Chakhunashvili K; Kvirkvelia E; Todua N; Chakhunashvili DG
BMC Pediatr; 2024 Feb; 24(1):138. PubMed ID: 38395819
[TBL] [Abstract][Full Text] [Related]
60. Treatment of infantile hemangiomas with propranolol: clinical guidelines.
Szychta P; Stewart K; Anderson W
Plast Reconstr Surg; 2014 Apr; 133(4):852-862. PubMed ID: 24352207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
